Sonova Holding AG (OTCMKTS:SONVY – Get Free Report) has earned an average recommendation of “Hold” from the six brokerages that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company.
Several analysts have recently weighed in on SONVY shares. Hsbc Global Res upgraded shares of Sonova from a “hold” rating to a “strong-buy” rating in a research report on Friday. HSBC raised Sonova to a “buy” rating in a report on Friday.
Get Our Latest Research Report on SONVY
Sonova Stock Performance
About Sonova
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
See Also
- Five stocks we like better than Sonova
- What Are Some of the Best Large-Cap Stocks to Buy?
- T-Mobile US: The Un-Carrier Is an Indisputable Buy on the Dip
- Investing in Construction Stocks
- 3M Stock: 4 Compelling Reasons to Buy, 1 Big Reason to Pass
- What Investors Need to Know About Upcoming IPOs
- Kroger: This Must-Own Staples Stock Thrives in Every Market
Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.